IART Q4 2023 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$397M-0.2% YoY

Gross Profit

$226M57.0% margin

Operating Income

$36M9.1% margin

Net Income

$20M5.0% margin

EPS (Diluted)

$0.25

QoQ Revenue Growth

+3.8%

Cash Flow

Operating Cash Flow

$59M

Free Cash Flow

$34M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$3.8B

Total Liabilities

$2.2B

Stockholders' Equity

$1.6B

Cash & Equivalents

$276M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$397M	$398M	-0.2%
Gross Profit	$226M	$250M	-9.4%
Operating Income	$36M	$68M	-46.9%
Net Income	$20M	$53M	-62.5%